ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for alerts 실시간 알림, 사용자 정의 포트폴리오 및 시장 동향을 받으려면 등록하세요.
Boundless Bio Inc

Boundless Bio Inc (BOLD)

2.35
-0.22
(-8.56%)
마감 23 11월 6:00AM
2.4601
0.1101
(4.69%)
시간외 거래: 9:12AM

포트폴리오 강화: 실시간 토론 및 실행 가능한 거래 아이디어.

주요 통계 및 세부정보

가격
2.4601
매수가
2.46
매도가
2.54
거래량
295,442
2.33 일간 변동폭 2.70
2.04 52주 범위 59.97
market_cap
전일 종가
2.57
개장가
2.58
최근 거래 시간
2
@
2.5399
마지막 거래 시간
재정 규모
US$ 751,266
VWAP
2.5429
평균 볼륨(3m)
62,981
발행 주식
22,300,043
배당수익률
-
주가수익률
-1.06
주당순이익(EPS)
-2.22
매출
-
순이익
-49.43M

Boundless Bio Inc 정보

Boundless Bio, Inc., a clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by targeting extrachromosomal DNA. Its lead product candidate is BBI-355, an oral inhibitor of checkpoint kinase 1 that is in Phase 1/2 clinical t... Boundless Bio, Inc., a clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by targeting extrachromosomal DNA. Its lead product candidate is BBI-355, an oral inhibitor of checkpoint kinase 1 that is in Phase 1/2 clinical trial in patients with oncogene amplified cancers. The company is also developing BBI-825, an oral inhibitor of ribonucleotide reductase, which is in Phase 1/2 clinical trial in cancer patients with resistance gene amplifications; and ecDTx 3 program targeting a kinesin involved with the cellular mechanism for segregation of ecDNA. Boundless Bio, Inc. was formerly known as Pretzel Therapeutics, Inc. and changed its name to Boundless Bio, Inc. in July 2019. The company was incorporated in 2018 and is headquartered in San Diego, California. 더 보기

섹터
Pharmaceutical Preparations
산업
Pharmaceutical Preparations
웹사이트
본부
Wilmington, Delaware, USA
설립됨
-
Boundless Bio Inc is listed in the Pharmaceutical Preparations sector of the 나스닥 with ticker BOLD. The last closing price for Boundless Bio was US$2.57. Over the last year, Boundless Bio shares have traded in a share price range of US$ 2.04 to US$ 59.97.

Boundless Bio currently has 22,300,043 shares in issue. The market capitalisation of Boundless Bio is US$57.31 million. Boundless Bio has a price to earnings ratio (PE ratio) of -1.06.

BOLD 최신 뉴스

Boundless Bio Reports Third Quarter 2024 Financial Results and Business Highlights

Enrollment progressing in BBI-355 POTENTIATE and BBI-825 STARMAP clinical trials, with initial proof-of-concept data expected in the second half of 2025 Cash position of $167 million, with...

Boundless Bio to Participate in the 2024 Guggenheim Global Healthcare Conference

SAN DIEGO, Nov. 05, 2024 (GLOBE NEWSWIRE) -- Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative...

Boundless Bio Announces Departure of Chief Financial Officer

SAN DIEGO, Oct. 14, 2024 (GLOBE NEWSWIRE) -- Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative...

Boundless Bio to Participate in the 2024 Cantor Global Healthcare Conference

SAN DIEGO, Sept. 11, 2024 (GLOBE NEWSWIRE) -- Boundless Bio (Nasdaq: BOLD), a clinical-stage oncology company interrogating extrachromosomal DNA (ecDNA) biology to deliver transformative...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
1-0.7699-23.83591331273.233.232.041270132.86858547CS
4-0.5299-17.72240802682.993.752.04739503.04926401CS
12-1.0149-29.20575539573.4754.722.04629813.26495093CS
26-8.1899-76.900469483610.6512.262.04837714.49472262CS
52-57.5099-95.897782224459.9759.972.04684797.2880041CS
156-57.5099-95.897782224459.9759.972.04228577.2880041CS
260-25.8699-91.316272502628.33602.048376448.88438607CS

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
PDYNPalladyne AI Corporation
US$ 4.59
(129.50%)
83.07M
QMCOQuantum Corporation
US$ 9.11
(126.62%)
39.48M
NANano Labs Ltd
US$ 8.26
(89.02%)
2.03M
XCURExicure Inc
US$ 18.60
(71.27%)
4.59M
SKKSKK Holdings Limited
US$ 1.75
(59.09%)
107.47M
AMIXAutonomix Medical Inc
US$ 6.21
(-54.07%)
946.09k
CETXCemtrex Inc
US$ 0.1146
(-41.74%)
24.39M
MSWMing Shing Group Holdings Ltd
 5.90
(-35.52%)
417.08k
RMSGReal Messenger Corporation
US$ 3.09
(-26.25%)
313.51k
ENSCEnsysce Biosciences Inc
US$ 0.4414
(-25.49%)
4M
ELABElevai Labs Inc
US$ 0.0201
(-0.50%)
415.86M
NVDANVIDIA Corporation
US$ 141.95
(-3.22%)
229.92M
SMCISuper Micro Computer Inc
US$ 33.15
(11.62%)
155.43M
VRPXVirpax Pharmaceuticals Inc
US$ 0.5501
(-6.72%)
154.16M
SOUNSoundHound AI Inc
US$ 8.24
(18.05%)
103.6M
wadegarret wadegarret 17 초 전
Wadegarret portfolio- up 11% YTD/up 190% since 2022
PureZoob PureZoob 35 초 전
There’s never a nice day with this stock… It’s been a mess for the past 18 months
SYAXF
TheDane TheDane 1 분 전
After a drop from $49! Don’t forget that.
SMCI
Almosthere Almosthere 3 분 전
Maybe they already have a buyer lined up..
LQMT
srm4u srm4u 4 분 전
Office of Management and Budget director: Russ Vought
Trump announced he will name Russ Vought as OMB director. Vought served in this role in the latter part of the first Trump administration.

Vought was involved in writing the conservative Heritage Foundation's Project 2025,
Ecomike Ecomike 4 분 전
Nope. They can just rent the Google, or Amazon cloud AI
NFTM
TheDane TheDane 4 분 전
Filling that gap, which is inevitable, is a signal to load up.
SMCI
europa7 europa7 4 분 전
here ya go delerious...Fox News article re new Treasury Secretary nominee...cheers

Trump nominates Scott Bessent as treasury secretary; picks Russ Vought to lead budget office
"...Bessent was a key economic policy adviser and fundraiser for the Trump campaign..."
https:/
XLMUSD
train21 train21 5 분 전
RIGHT AT SOME POINT THIS WILL RUN
PSRU
MiamiGent MiamiGent 6 분 전
President Trump Nominates Russ Vought for Director of Office of Management and Budget (OMB)
President Trump has announced the official nomination of Russ Vought for the position of OMB Director. Russ Vought ran the Office of Management and Budgets under President Trump in the first administra
srm4u srm4u 7 분 전
The 25 Most Important Recipes of the Past 100 Years
NOV 20, 2024

Read all the stories from Slate’s 25 Most Important American Recipes of the Past 100 Years.

When we initially reached out to scores of chefs, recipe writers, historians, and food luminaries for nomi
Bubae Bubae 8 분 전
A little mark the close manipulation ten seconds before the close to mask the real activity today. 😄Someone unloaded the entire days selling into the bid at around 2:00 at $0.0004.

https://investorshub.advfn.com/uimage/uploads/2024/11/22/xunkuTrades_11222024.jpg
GRST
Moonboy1 Moonboy1 9 분 전
If this busts out of that descending channel this is going to rip
BTCUSD
AKATITUS AKATITUS 9 분 전
Yup
KULR
train21 train21 10 분 전
RIGHT AT SOME POINT THIS WILL RUN
PSRU
Optimist101 Optimist101 10 분 전
On the positive side this case victory sets up wonderfully for Google as in that case the patent is already deemed valid in all further cases. And now that Samsung has been deemed infringing I feel that leaves no wiggle room left for Google and now trial is all about what do they owe for infringing
NLST
WhAtEvA1 WhAtEvA1 10 분 전
You'll have to find somewhere to hide your face when the FDA clears radiogel for human trials. Your Betaglue can't even boast of putting anything together for review by the FDA.
RDGL
srm4u srm4u 10 분 전
How DMSO Heals the Eyes, Ears, Nose, Mouth and Throat
November 22, 2024

STORY AT-A-GLANCE
Vision support — DMSO can help improve vision, treat conditions like macular degeneration, retinitis pigmentosa, cataracts, and may even restore sight in some cases. It also soothes
Mr Stockboy Mr Stockboy 11 분 전
Now I might have a tough decision no thanks to the 8K. AMRN is open to the option of a R/S.

Spin me a tale but the investor basically loses, as after the R/S the pps falls again. Value is totally loss.

If someone can legitimately make a case for R/S to the investor's ad
AMRN
arizona1 arizona1 12 분 전
Scuhmer had to cut a deal trying to get the last bit of confirmations through. People are upset, saying he caved in but 4 seats doesn't seem like much to me...

McConnell NEVER would have cut this deal.

Because this is what's wrong with it. He just didn't want his pre
TheDane TheDane 13 분 전
Was there news from Amazon today related to Ionq? I saw something mentioned on another board But there were no specifics.
IONQ

최근 히스토리

Delayed Upgrade Clock